Association of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men
Top Cited Papers
Open Access
- 1 November 2006
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 91 (11), 4335-4343
- https://doi.org/10.1210/jc.2006-0401
Abstract
Context: Although attention and concern about health disorders in aging men have been growing, the structure of psychological and somatic complaints of actual patients, not population-based cohorts, has not been elucidated in relation to sex hormone patterns and metabolism. Objective: The objective of the study was investigation of factors influencing complaint structures in aging male patients. Design: This was a cross-sectional cohort study. Setting: The study was conducted in an andrological outpatient department. Patients: Subjects included 434 consecutive male patients aged 50–86 yr. Main Outcome Measures: The following hypotheses were measured: 1) psychosomatic complaints and metabolic factors in aging male patients are related to sex hormone levels in a symptom-specific manner, and 2) patients form subcohorts. Results: A clear-cut threshold for late-onset hypogonadism was not found; rather, prevalence of psychosomatic symptoms and metabolic risk factors accumulated with decreasing androgen levels. For example, androgen-induced prevalence of loss of libido or vigor increased below testosterone concentrations of 15 nmol/liter (P < 0.001), whereas depression and diabetes mellitus type 2 (also in nonobese men) were significantly more present in men with testosterone concentrations below 10 nmol/liter (P < 0.001). Erectile dysfunction was identified as a composite pathology of metabolic risk factors, smoking, and depressivity, whereas only testosterone concentrations below 8 nmol/liter contributed to that symptom (P = 0.003). Cluster analysis revealed aging men to present within three independent groups characterized by psychosomatic complaints, metabolic disorders, and sexual health problems. These subgroups of patients exhibit distinct features in terms of androgen levels, age, and body mass index. Conclusions: There is no evidence that a uniform structure of testosterone concentrations and complaints exists within the cohort of elderly male patients. Rather, in aging male patients, psychosomatic complaints and metabolic risk relate to testosterone in a symptom-specific manner.Keywords
This publication has 24 references indexed in Scilit:
- Optimising workflow in andrology: a new electronic patient record and databaseAsian Journal of Andrology, 2006
- The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic ImplicationsEndocrine Reviews, 2005
- Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian menThe Lancet, 2005
- Dose-Dependent Effects of Testosterone on Sexual Function, Mood, and Visuospatial Cognition in Older MenJournal of Clinical Endocrinology & Metabolism, 2005
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendationsInternational Journal of Andrology, 2005
- X-Chromosome Inactivation Patterns and Androgen Receptor Functionality Influence Phenotype and Social Characteristics as Well as Pharmacogenetics of Testosterone Therapy in Klinefelter PatientsJournal of Clinical Endocrinology & Metabolism, 2004
- Prostate Volume and Growth in Testosterone-Substituted Hypogonadal Men Are Dependent on the CAG Repeat Polymorphism of the Androgen Receptor Gene: A Longitudinal Pharmacogenetic StudyJournal of Clinical Endocrinology & Metabolism, 2003
- Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging StudyJournal of Clinical Endocrinology & Metabolism, 2002
- Testosterone dose-response relationships in healthy young menAmerican Journal of Physiology-Endocrinology and Metabolism, 2001
- A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in SerumJournal of Clinical Endocrinology & Metabolism, 1999